Will September Be a Better Month for Pot Stocks?

After a rough August, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) could be poised to make a big recovery this month.

| More on:
Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Last month was not a good one for the cannabis industry. Still reeling from scandals and poor earnings, even Canopy Growth (TSX:WEED)(NYSE:CGC) fell to levels not seen in a long time, as it lost more than 25% of its share price in just one month.

Rival Aurora Cannabis was also down more than 9%. One of the lone bright spots was Aphria, which benefited from a strong quarter during the month.

However, now that the industry is one month closer to the legalization of edibles and is further removed from some disappointing earnings results, there could be much more positivity surrounding pot stocks.

Investors can sometimes have short memories, and the industry could certainly benefit from that right about now. With a fresh month, it could be a good opportunity for investors to pick up the pieces, with many pot stocks looking to be cheap buys, especially relative to where they’ve been in the past.

Is this the best buy today?

Canopy Growth may be the most enticing marijuana stock to buy today, and that’s why it was my top pick for the month.

Although a price-to-sales multiple of around 40 is still very high, it’s nowhere near the triple digits we’ve come to expect for pot stocks. But given the growth potential for the industry in global market, there’s still certainly lots of upside left for Canopy Growth and its peers to continue rising in value.

One of the most recent estimates by Grand View Research has the legal marijuana market projected to grow to US$66.3 billion as early as 2025. The company is expecting a compounded annual growth rate of 23.9%, pointing to greater adoption of marijuana for medical purposes as being a key driver behind its long-term growth.

And with more places around the world going to legalize pot, the market is growing with each new market that becomes open for business.

Canopy Growth has already positioned itself for a lot of growth with deals involving other industries and in various parts of the world. While its position atop of the industry may be questionable these days, there’s no denying that it’s still one of the most well-known pot stocks in the industry.

And if there’s a recovery that’s set to happen, it’ll likely be led by Canopy Growth. While it had one of the largest declines last month, it could be due for a big rally in September.

Bottom line

Pot stocks have proven to be a volatile bunch, and while they’re down now, there’s likely to be a lot of excitement surrounding them as we get closer to the launch of edibles.

There’s nothing like a new wave of products that can get investors excited about the industry’s growth prospects. And unless the cannabis industry gets hit with some bad news this month, I’d expect to see pot stocks make a strong recovery, especially in light of how bad they’ve taken a hit in recent months, and with investors looking for possible deals.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »